Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Malignant Glioma [Phase 1, Phase 2]

View source ↗

Summary

A completed phase 1/2 clinical trial evaluating immunotoxin therapy for malignant glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Immunotoxin therapy

Snippet

Sponsor: New Approaches to Brain Tumor Therapy Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED